Cardinal Health, Inc. CAH
220.22
(2.40)
(1.08%)
as of 25 Sep
- Market cap
- $51.6B
- P/E
- 30.3×
Follow CAH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Cardinal Health, Inc. (CAH) Gross margin
Cardinal Health, Inc.'s gross margin over the twelve months to 30 June 2026 was 3.84%. Over the past ten years it has ranged from 3.27% (fiscal 2024) to 5.57% (fiscal 2015); the current reading is higher than 42% of that period. That is below the Medical Distribution industry median of 8.01% and below the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 3.84% | 0.17 |
| FY2025 | 3.67% | 0.40 |
| FY2024 | 3.27% | (0.08) |
| FY2023 | 3.35% | (0.23) |
| FY2022 | 3.58% | (0.59) |
| FY2021 | 4.17% | (0.32) |
| FY2020 | 4.49% | (0.21) |
| FY2019 | 4.70% | (0.55) |
| FY2018 | 5.25% | 0.22 |
| FY2017 | 5.03% | (0.35) |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 4.02% | (0.08) |
| Mar 2026 | 4.10% | 0.45 |
| Dec 2025 | 3.65% | 0.03 |
| Sep 2025 | 3.62% | (0.04) |
| 42 more quarters | Free account |
Against its own ten years
Low 3.27%
High 5.57%
Ten-year median
4.33%
Current reading's percentile
42
Gross margin against peers
| Company | Gross margin |
|---|---|
| ACH Accendra Health, Inc. compare | 44.8% |
| FOCL FocalTherics compare | 44.5% |
| HSIC Henry Schein, Inc. compare | 31.3% |
| COSM Cosmos Health Inc. compare | 10.3% |
| YI 111, Inc. Sponsored ADR compare | 5.74% |
| COR Cencora, Inc. compare | 3.97% |
| CAH Cardinal Health, Inc. | 3.84% |
| MCK McKesson Corporation compare | 3.64% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| Medical Distribution industry median | 8.01% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on CAH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement